Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 4/20 | 0.78 |
| ▸ | BCR | P11274 | 4/20 | 0.78 |
| ▸ | PRKCA | P17252 | 4/20 | 0.78 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.66 |
| ▸ | EGFR | P00533 | 2/20 | 0.65 |
| ▸ | SRC | P12931 | 2/20 | 0.65 |
| ▸ | PRKACA | P17612 | 2/20 | 0.65 |
| ▸ | PRKACG | P22612 | 2/20 | 0.65 |
| ▸ | PRKACB | P22694 | 2/20 | 0.65 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.65 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.54 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.54 |
| ▸ | PIK3CG | P48736 | 4/20 | 0.54 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.54 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.53 |
| ▸ | IGF1R | P08069 | 2/20 | 0.53 |
| ▸ | SYK | P43405 | 2/20 | 0.52 |
| ▸ | CDK2 | P24941 | 2/20 | 0.52 |
| ▸ | GSK3B | P49841 | 1/20 | 0.52 |
| ▸ | SMO | Q99835 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8837857 | 0.92 | ABL1 (0.76) | ABL1BCRPRKCACSNK2A1EGFR | |
| SCHEMBL8837828 | 0.90 | ABL1 (0.73) | ABL1BCRPRKCACSNK2A1EGFR | |
| SCHEMBL8837903 | 0.89 | PRKCA (0.83) | ABL1BCRPRKCACSNK2A1EGFR | |
| SCHEMBL8837778 | 0.88 | ABL1 (0.77) | ABL1BCRPRKCACSNK2A1EGFR | |
| SCHEMBL8837795 | 0.88 | ABL1 (0.80) | ABL1BCRPRKCACSNK2A1EGFR | |
| SCHEMBL1255 | 0.88 | ABL1 (0.80) | ABL1BCRPRKCACSNK2A1EGFR | |
| SCHEMBL1269 | 0.88 | ABL1 (1.00) | ABL1BCRPRKCACSNK2A1EGFR | |
| SCHEMBL8837915 | 0.87 | ABL1 (0.79) | ABL1BCRPRKCACSNK2A1EGFR | |
| SCHEMBL8837807 | 0.87 | PRKCA (0.79) | ABL1BCRPRKCACSNK2A1EGFR | |
| SCHEMBL8837787 | 0.87 | ABL1 (0.71) | ABL1BCRPRKCACSNK2A1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5612340-A | ANTITUMOR AGENTS | CIBA-GEIGY CORPORATION (US) | 1997-03-18 | — | — | US | claimed |
| US-5612340-A | ANTITUMOR AGENTS | CIBA-GEIGY CORPORATION (US) | 1997-03-18 | — | — | US | disclosed |
| EP-0672035-A1 | PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | Novartis AG (CH) | 1995-09-20 | — | — | EP | disclosed |
| WO-1995009847-A1 | PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | CIBA-GEIGY AG (CH) | 1995-04-13 | — | — | WO | disclosed |